Skip to product information

Cervical Screening - Pap Smear Test

Cervical Screening - Pap Smear Test

Regular price $400.00
Regular price Sale price $400.00
Save Sold out
10 People are looking at this
View full details
Selected Variant Image
Cervical Screening - Pap Smear Test
Regular price $400.00
Regular price Sale price $400.00
Selected Variant Image
Cervical Screening - Pap Smear Test
Regular price $400.00
Regular price Sale price $400.00
  • Description

  • Why Us?

Pap Smears - Cervical Cancer Screening

Cervical cancer has been the 7th commonest cancer among females in Hong Kong and it is the 8th leading cause of female cancer deaths in Hong Kong. Cervical cancer is often asymptomatic at an early stage. Early detection by cervical cancer screening is a must routine checkup for females after 21 years old.

According to the American Cancer Society (ACS) and American College of O&G (ACOG) guidelines, Women should start routine Cytology Cervical Cancer Screening - Pap Smears from the age of 21 to 65 and for every 3 years if no prior abnormal cervical cancer screening test result.

Sampling is simple and only takes several minutes. You will lie on your back and the doctor will use a special instrument called a speculum to gently open the vagina so that the cervix can be seen. A special device will be used to brush cells from the neck of the womb.


Doctor Consultation
 - Detailed History

Lab Test
 - Pap Smaer





Clearbridge Health Limited is an integrated healthcare group with a focus on the delivery of precision medicine with businesses comprising of laboratory testing services, medical centres/clinics and strategic equity participation in complementary precision medical technology companies. We are present in more than 10 countries around the world and have plans to further expand our presence in Pan Asia. Working closely with healthcare professionals and globally-accredited laboratories, Clearbridge Health offers patient care through precision diagnostics, empowers clinicians and healthcare professionals to make reliable and accurate diagnoses, providing fresh insights into disease management, customising prevention and treatment programmes that are personalised and timely. Listed on the Catalist Board of the SGX-ST, Clearbridge Health Limited Group of Companies continues to provide effective ways to detect cancer, critical illness, and other lifestyle diseases in the world today.

VISION
Redefining healthcare in Asia with precision.
Empowering patient care with clarity.

MISSION
Setting a new standard for personalized care through the integration of healthcare services, medical technology and data science.

CORE VALUES
Kindness You always come first
Confidence We believe that better outcomes start with precise insights
Dependability Our people – they are our edge
Respect Professionalism in every circumstance
Trust Delivering healthcare services with utmost integrity